Literature DB >> 7851025

Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease.

G Carayanniotis1, G C Huang, L B Nicholson, T Scott, P Allain, A M McGregor, J P Banga.   

Abstract

Grave's disease (GD) is a common disorder characterized by the presence of autoantibodies to the thyrotropin receptor. In the past, the exceedingly low expression of the thyrotropin receptor on thyrocytes has not allowed its purification in quantities sufficient to investigate the establishment of an animal model for this disease. In this study, we have purified the 398-amino acid, extracellular region of the human thyrotropin receptor (TSH-R.E) from insect cells using recombinant baculovirus, and explored its immunopathogenic properties in H-2b,d,q,k,s strains of mice. The receptor preparation was highly immunogenic since it elicited strong specific proliferative T cell responses as well as IgG responses in all strains tested. In addition, hyperimmunization with TSH-R.E induced (i) serum antibodies that blocked the binding of 125I-TSH to its receptor, a common feature of GD autoantibodies; and (ii) IgG that reacted with a synthetic peptide (residues 32-54) from the N-terminus of the receptor, a region implicated in the binding of thyroid stimulating antibodies. In SJL animals only, a weak antibody response to two other thyroid antigens, thyroglobulin and thyroid peroxidase, was also observed. The presence of these antibodies, however, was not accompanied by a detectable alteration in thyroid function as assessed by the measurement of serum TSH, T4 and iodine levels. Also mononuclear infiltration of the thyroid gland or morphological changes compatible with an activation state of thyrocytes were not apparent in TSH-R-challenged mice. In contrast, mice treated with the anti-oxidant aminotriazole showed a dramatic increase in serum TSH levels and an activated follicular epithelium. These data demonstrate that a highly immunogenic TSH-R.E in mice does not necessarily provide a proper stimulus for the induction of a hyper- or hypothyroid status as defined by hormonal or histological criteria. Main reasons for the inability to induce receptor-specific antibodies that affect thyroid function such as those generated in GD are likely to be the inappropriate folding of the recombinant extracellular domain of the receptor, or the xenogeneic nature of the autoantigen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851025      PMCID: PMC1534295          DOI: 10.1111/j.1365-2249.1995.tb05548.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

1.  Determination of iodine and bromine in plasma and urine by inductively coupled plasma mass spectrometry.

Authors:  P Allain; Y Mauras; C Dougé; L Jaunault; T Delaporte; C Beaugrand
Journal:  Analyst       Date:  1990-06       Impact factor: 4.616

2.  Role of N-terminal region of the thyrotropin (TSH) receptor in signal transduction for TSH or thyroid stimulating antibody.

Authors:  M Ohmori; T Endo; M Ikeda; T Onaya
Journal:  Biochem Biophys Res Commun       Date:  1991-07-31       Impact factor: 3.575

3.  The thyrotrophin hormone receptor of Graves' disease: overexpression of the extracellular domain in insect cells using recombinant baculovirus, immunoaffinity purification and analysis of autoantibody binding.

Authors:  G C Huang; M J Page; L B Nicholson; K S Collison; A M McGregor; J P Banga
Journal:  J Mol Endocrinol       Date:  1993-04       Impact factor: 5.098

4.  Biological activities of rabbit antibodies against synthetic human thyrotropin receptor peptides representing thyrotropin binding regions.

Authors:  S Sakata; T Ogawa; I Matsui; T Manshouri; M Z Atassi
Journal:  Biochem Biophys Res Commun       Date:  1992-02-14       Impact factor: 3.575

5.  Studies of thyroid xenografts from Graves' disease in severe combined immunodeficient mice.

Authors:  T Morita; N Yoshikawa; F Akasu; E Resetkova; G Arreaza; N Miller; C Jamieson; R Volpé
Journal:  J Clin Endocrinol Metab       Date:  1993-07       Impact factor: 5.958

6.  A receptor assay for the measurement of TSH receptor antibodies in unextracted serum.

Authors:  K Southgate; F Creagh; M Teece; C Kingswood; B Rees Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1984-05       Impact factor: 3.478

7.  Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse.

Authors:  S A Stein; E L Oates; C R Hall; R M Grumbles; L M Fernandez; N A Taylor; D Puett; S Jin
Journal:  Mol Endocrinol       Date:  1994-02

8.  Isolation of TSH and LH/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing.

Authors:  A L Frazier; L S Robbins; P J Stork; R Sprengel; D L Segaloff; R D Cone
Journal:  Mol Endocrinol       Date:  1990-08

9.  Identification of a thyroiditogenic sequence within the thyroglobulin molecule.

Authors:  E Chronopoulou; G Carayanniotis
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

10.  Analysis of autoantibody reactivity in patients with Graves' disease using recombinant extracellular domain of the human thyrotropin receptor and synthetic peptides.

Authors:  J L Fan; G S Seetharamaiah; R K Desai; J S Dallas; N M Wagle; B S Prabhakar
Journal:  Autoimmunity       Date:  1993       Impact factor: 2.815

View more
  9 in total

1.  Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.

Authors:  S Costagliola; M C Many; J F Denef; J Pohlenz; S Refetoff; G Vassart
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

2.  Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells.

Authors:  S Akkaraju; K Canaan; C C Goodnow
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

Review 3.  An animal model of Graves' disease: understanding the cause of autoimmune hyperthyroidism.

Authors:  L D Kohn; N Shimojo; Y Kohno; K Suzuki
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

4.  Superiority of thyroid peroxidase DNA over protein immunization in replicating human thyroid autoimmunity in HLA-DRB1*0301 (DR3) transgenic mice.

Authors:  J C Flynn; A Gardas; Q Wan; M Gora; G Alsharabi; W Z Wei; A A Giraldo; C S David; Y M Kong; J P Banga
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

5.  Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule.

Authors:  N Shimojo; Y Kohno; K Yamaguchi; S Kikuoka; A Hoshioka; H Niimi; A Hirai; Y Tamura; Y Saito; L D Kohn; K Tahara
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.

Authors:  K Barrett; E Liakata; P V Rao; P F Watson; A P Weetman; P Lymberi; J P Banga; G Carayanniotis
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

7.  Induction of thyroiditis in mice with thyrotropin receptor lacking serologically dominant regions.

Authors:  S H Wang; G Carayanniotis; Y Zhang; M Gupta; A M McGregor; J P Banga
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

8.  Characterization of the murine immune response to the murine TSH receptor ectodomain: induction of hypothyroidism and TSH receptor antibodies.

Authors:  H Vlase; M Weiss; P N Graves; T F Davies
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

Review 9.  Excessive Cytosolic DNA Fragments as a Potential Trigger of Graves' Disease: An Encrypted Message Sent by Animal Models.

Authors:  Yuqian Luo; Aya Yoshihara; Kenzaburo Oda; Yuko Ishido; Koichi Suzuki
Journal:  Front Endocrinol (Lausanne)       Date:  2016-11-14       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.